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ABSTRACT 
Legitimate and illegitimate use of lysergic acid diethylanide (LSD) 
increased dramatically in the 1960 1 s. Since then, a number of studies 
have shown that LSD induces -psychotic symptoms in the user, suggesting a 
possible correlation between exposure to LSD and certain psychoses. 
This hypothesis is supported by repeated observations that LSD inhibits 
5-HT systems in the brain and that central 5-HT systems may be implicated 
in certain psychoses. The present study was designed to test the hypoth-
esis that chronic administration of LSD to rats has an observable effect 
on 5-HT neuronal functioning in the brain. Rats were exposed to varying 
doses of LSD, and sacrificed 1 or 14 days after the last dose. Altera-
tion in the 5-HT system was estimated by measurement of turnover of 5-HT, 
synaptosomal uptake of (3H)5-HT, and the extent of (3H)5-HT and (3H)-
spiroperidol binding. The results do not support the hypothesis. Chronic 
LSD administration had no effect on 5-HT turnover, uptake, or receptor 
binding. In light of these results, the possibility exists that LSD 
induces a psychotic effect in humans by other mechanisms. The possibility 
also exists that the effect in humans is not paralleled in rats. 
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INTRODUCTION 
Since the accidental discovery by Hofmann of the intense hallucina-
tory effect of d~lysergic acid diethylamide (LSD) in 1943, this drug has 
been among the most noteworthy in modern times. As one of the most 
potent hallucinogens known to man, LSD has been the basis of an immense 
body of published I iterature. LSD has been employed for a variety of 
legitimate purposes, including use by psychiatrists for the treatment of 
patients with neurotic disorders (Chandler and Hartman, 1960; Ling and 
Buckman, 1963; and Levine and Ludwig, 1964). 
The subjective effects of LSD have been characterized as consisting 
of impairments of sensory perception and thought processes. The term 
11 illucinogenic11 has been coined for use in association with LSD, since 
the drug is described as altering reality rather than producing hallucin-
ation (Sankar, 1975) in the mind of the user. 
111 icit use of LSD has become popular since the drug appeared in 
the 1960 1 s. However, numerous accounts have been recorded by psychia-
trists describing patients who have experienced psychotic episodes per-
sisting or beginning weeks or even months after their last exposure to 
the drug. For example, Elkes (1963) described delayed reactions to LSD 
such as changes in mood, perceptual distortions, depersonalization, and 
confusion. Other discussions of psychoses presumably induced by LSD 
include Cohen (1960), Fink, Simeon, Hawe, and ltil (1966), and Ungerleider, 
Fisher and Fuller (1966). 
The psychotic symptoms have been characterized in the DSM-I I I. 1981, 
as comprising two syndromes. These are an organic delusional syndrome 
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and an organic affective syndrome. The delusional syndrome consists of 
delusions, or the belief in something not real, while the patient is in 
a normal state of consciousness. The organic affective syndrome consists 
of mood instability. Both of these disorders are associated with hallu-
cinations, paranoia and personality disintegration. Another psychiatric 
disorder arising from the use of LSD is the flashback phenomenon . Flash-
backs are repetitions of hallucinatory perceptions occurring weeks or 
months after the effect of the drug has worn off. This phenomenon is 
described by Welpton (1968) and Horowitz (1969). 
The biochemical basis of these LSD-induced psychotic effects has 
been the object of a number of scientific inquiries. It has been shown 
that intravenously administered LSD has a half-1 ife in the human body of 
approximately three hours (Aghajanian and Bing, 1964). This suggests a 
rapid elimination of the drug. This, in association with the psychiatric 
data, suggests that LSD may be causing some effect that persists after 
i ts remova 1 . 
A large amount of research has been carried out in an attempt to 
elucidate the mechanism of action of LSD in the central nervous system. 
Rosencrans et al (1967) showed that acute exposure to LSD caused rat 
brain 5-HT to increase and level off after 90 minutes. Aghajanian ~ ~ 
(1972), using microiontophoretic methods , administered LSD to the mid-
brain raphe nuclei. This caused a potent inhibit ion of the rhythmic fir-
ing of the 5-HT neuronal cell bodies residing there. Aghajanian ~~ 
(1982) measured intracellular recordings from the rat raphe which demon-
strated inhibition of 5-HT neuronal firing by LSD . It has been proposed 
by some researchers (Diaz and Huttenan , 1972; Peters 1973) that this 
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profound effect of LSD on 5-HT neurons could be the mechanism of LSD-
induced psychotic manifestations. Weight is added to this hypothesis 
due to the extensive study of biogenic amines including 5-HT in schizo-
phrenia and related psychotic disorders. The biogenic amine hypothesis 
intimately relates 5-HT with psychosis (Baldessarini ~ ~. 1972; Garver 
and Davis, 1979). 
Researchers have attempted to examine the effects of LSD on 5-HT 
turnover VJith conflicting results. Diaz and Huttenan (1972) administered 
20 ug/kg LSD to rats orally on a daily basis for one month. They 
reported an increase in 5-HT in the whole brain preparation. Other 
research (Peters, 1973; Peters, 1976) reported a decrease in 5-HT turn-
over in the midbrain after administration of 20 ug/kg/day LSD for various 
periods of time. Peters (1974) reported an increase in 5-HT turnover 
when 100 ug/kg/day was administered. 
The doses and time periods chosen for the experiments carried out 
in our study were decided upon based on this previously reported data. 
Treatment conditions consisting of similar time periods but much larger 
doses of LSD (10 times the ED 50 ) were utilized in order to insure the 
occurrence of an effect if one was to be observed. 
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MATERIALS AND METHODS 
In recent years, a variety of biochemical methods have been devel-
oped with which researchers can study the activity of neurons and neuro-
transmitters. Three biochemical parameters which can be utilized to 
determine the integrity of~ neurotransmitter system are neurotransmitter 
turnover, uptake of radiolabeled neurotransmitter, and the binding of 
radioligands to neurotransmitter receptors. 
Turnover of a neurotransmitter refers to the renewal of the sub-
stance: Certain ass~mptions should be met in order to measure the turn-
over of 5-HT in the brain (Neff~~. 1968). These assumptions can be 
summarized as follows: (1) 5-HT enters the system by synthesis and is 
lost by metabolism, (2) a steady state exists where the rate of formation 
of 5-HT equals its degradation, (3) the turnover rate of 5-HT remains 
consistent but not necessarily equal during experimentation, and (4) no 
distinction is made between newly synthesized and old molecules of 5-HT. 
Tozer et al (1966) and Neff and Tozer (1968) have evaluated the measure-
ment of 5-HT turnover after pargyl ine administration. The levels of 5-HT 
continue to rise after inhibition of MAO until the rising levels of 5-HT 
block the process (Millard et~. 1972; Baumann and Valdmeier, 1981). 
This phenomenon has been called 11 end product inhibition11 • 
The method of measuring high-affinity synaptosomal uptake of radio-
labeled neurotransmitters began with the development of methods which 
allowed intact nerve endings to be pinched off and separated (Gray and 
Whittaker, 1962). It was later shown that these high-affinity uptake 
mechanisms were sodium-dependent, ouabain-sensitive, and saturable 
(Bogdanski~~. 1968). Kuhar et al (1972) demonstrated that the uptake 
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of (3H)5-HT in rat forebrain was carried out by 5-HT neurons. By lesion-
ing the midbrain raphe, 5-HT uptake was selectively reduced. The para-
meters of this experimental methodology were worked out by Shaskan and 
Snyder (1970). A general description of the methodology was published 
by Kuhar (1973). More recently, high-affinity synaptosomal uptake has 
been used to measure long-term effects of methylamphetamine on 5-HT 
neurons in rat brain (Ricaurte et~' 1980). 
The most recently developed methodology utilized to detect altera-
tions in neurotransmitter systems is radiol igand-receptor binding tech-
nique. In rat brain preparations, (3H)5-HT has been shown to bind in a 
saturable fashion and with regional variations consistent with the theor-
ized location of the 5-HT postsyraptic receptor (Bennet and Snyder, 1975). 
At the same time, other researchers came to similar conclusions using 
membrane preparations (Fillion~~. 1975), These results have since 
been reproduced with a reasonable amount of consistency (Fill ion et~. 
1977; Peroutka~~' 1979). Recent experimentation has also advanced 
the hypothesis that there are subgroups of 5-HT receptors 0ith differing 
binding capabilities for various radioligands. 
In the rat cerebral cortex, two main subgroups of 5-HT receptors 
have been hypothesized to exist. One group of receptors has a high 
affinity for (3H)5-HT, while the other group of receptors has a high 
affinity for 3H-spiropridol and other 5-HT antagonists (Leysen and 
Laduron, 1977; Quik ~~. 1978). Spiroperidol is a butyrophenone 
neuroleptic drug originally developed for clinical use but judged to be 
unsuitable due to severe side effects. In the cortex , (3H)5-HT and (3H)-
spiroperido1 have been shown to be displaceable by LSD, and (3H)-LSD has 
Page 7 
been shown to bind to the sites of both radial igands (Creese and Snyder, 
1978; Peroutka and Snyder, 1979; and Seeman~~. 1980). Both 5-HT and 
spiroperidol have been shown to displace (3H)-LSD from cortical binding 
sites (Peroutka and Snyder, 1979). The high-affinity (3H)-spiroperidol 
binding site has been hypothesized to be serotonergic due to the ability 
of 5-HT antagonists such as LSD, cinanserin, and mianserin to displace 
it from cortical binding sites, where it is most abundant (Peroutka and 
Snyder, 1981). This evidence combined suggests that 5-HT and spiroperi-
dol bind to separate subgroups of 5-HT receptors in the cerebral cortex 
and that LSD binds to both. Disagreement does exist, however, to the 
hypothesis that (3H)-spiroperidol labels a 5-HT receptor (Middlemiss~ 
~, 1980). It is interesting to note that this is due to conflicting 
results, and not theoretical argument. 
Although lesions of the midbrain raphe have been shown not to cause 
adaptive changes in either of the two subgroups of receptors described 
above (Blackshear~~. 1981), chronic administration of tricyclic anti-
depressants has been shown to produce a decrease in the number of cerebral 
~ortex 5-HT receptor binding sites (Segawa et~. 1979; Kellar~~. 
1981; and Maggi~~. 1981). Alterations in (3H)-spiroperidol binding 
have been found in rat striatum after chronic methylamphetamine adminis-
tration (Akiyama~~. 1982). · 
The purpose of this project is to gain a deeper understanding of the 
mechanism by which LSD acts on the 5-HT system in the cerebral cortex and 
the rest of the brain. We have attempted to identify and characterize 
adaptive changes in the 5-HT system after chronic administration of high 
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doses of LSD. It is hypothesized that the LSD-induced psychoses diagnosed 
by psychiatrists can be linked to altered functioning of the 5-HT system. 
If this is so, then demonstration of induced biochemical adaption will 
greatly enhance the understanding of the causes and effects of psychoses. 
General Methods 
All rats used in these experiments were male Long-Evans (Charles 
River Breeding Laboratories, Waltham, Massachusetts) weighing between 
200-250 grams at time of sacrifice. All treatments of LSD to rats were 
administered via the intraperitoneal route. All rats were guillotined 
without anesthesia. Whole brains were rapidly removed over ice . The 
brains were dissected based on descriptions by Glowinski and Iversen 
(1966) with modifications. The cerebral hemispheres were separated with 
one stroke of a spatula. The cortices were peeled back and stripped from 
the underlying tissue. Cortices used in turnover studies were assayed 
immediately after sacrifice. Tissue used in uptake and binding studies 
was stored at -7ooc until assay (less than four weeks). 
Treatments for administration of LSD consisted of the same pair of 
conditions for all three methods utilized. Rats were treated with 1 
mg/kg/day LSD for 14 consecutive days followed by one drug-free day prior 
to sacrifice, or they were treated with 1 mg/kg/day LSD for 14 consecu-
tive days followed by 14 drug-free days prior to sacrifice. In the turn-
over studies, additional experiments were conducted using varying condi-
tions. These were an acute study of 100 ug/kg LSD at six hours prior to 
sacrifice; seven consecutive days of treatment with 1 mg/kg/day LSD fol-
lowed by 14 days without treatment prior to sacrifice, and 14 consecutive 
Page 9 
days of treatment with 0.5 mg/kg/day LSD followed by 14 drug-free days 
prior to sacrifice. 
In the turnover studies, rats were treated with the monamine oxidase 
inhibitor, pargyline, 75 mg/kg i.p. at 0, 2, or 4 hours prior to sacri-
fice. In the uptake studies, one grol!p of rats was given 75 ug of 5,6-
dihydroxytryptamine, a selective 5-HT .neurotoxin, two weeks prior to 
sacrifice. The 5,6-DHT was administered intracerebroventricularly as 
described by Noble~~ (1967) with a few differences. The stereotaxic 
apparatus used in this study was provided by David Kopf Company, Tujunga, 
California. 
Turnover Studies 
The method of Curzon and Green (1970) was used to measure 5-HT 
fluorescence. The determination of levels of 5-HT after pargyline was 
accomp 1 i shed by measuring _the f 1 uorescence of 5-HT bound to the fl uores-
cent marker compound, ortho-phthalaldehyde (OPT). The method was slightly 
modified by Ciarlone (1976). Tissue was first weighed, then homogenized 
in 10 volumes of acidified n-butanol using a polytron homogenizer at 
speed 4 for 30 seconds. Internal standards were used. These were added 
in 0.3 ml aliquots of 0. 1 N HCl to 3 ml of n-butanol. The samples were 
dissolved in a similar volume of HCl. These were centrifuged at 1,000 x 
g for five minutes. Two and one-half ml of the supernatant was aspirated 
and added to tubes containing 1 . 6 ml of 0. 1 N HCl and 5 ml of n-heptane. 
These were vigorously shaken for five minutes. The organic phase was 
then aspirated. A 0.2 ml aliquot of the aqueous phase was removed for 
analysis. Each sample was added to 1.2 ml of 4 mg% OPT and placed in a 
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bath of boiling water for 10 minutes. The samples were allowed to cool 
after removal. Fluorescence was read using an Aminco-Bowman spectrophoto 
fluorometer at 355 excitation and 470 emission. Values were expressed 
in ug 5-HT/gram tissue wet weight. 
Synaptosomal Uptake Studies 
The assay procedure was modified from the method of Coyle and 
Snyder (1979). The frozen tissue was weighed and deposited in 10 volumes 
of 0.32 M sucrose. This was then homogenized using a motor-driven teflon 
glass pestle with a clearance of 0.03 cm, at about 1,000 rpm. Ten up-
and-down strokes were used in homogenization. The homogenates were cen-
trifuged at 4°c at 700 x g for 10 minutes. The pellet was then discarded. 
The synaptosomal homogenate was divided into six aliquots of 0.2 ml each. 
These were evenly divided among o0 c and 37°c incubations. The 0.2 ml 
synaptosomal homogenates were each added to 0.8 ml of incubation medium. 
The medium contained: NaCl (118.5 mM), KCl (4.8 mM), KH2P04 (1.2 mM), 
MgSOi+ (1.2 mM), NaHC0 3 (24.8 mM), EDTA (0.13 mM), pargyline (10- 5 M), 
ascorbate (0.2 mg/ml), d-glucose (1 mg/ml), and (3H)5-HT (10-8 M) (20 Ci/ 
mM, New England Nuclear Corporation, Boston, Massachusetts). The mixture 
was gassed for 15 minutes prior to use with 95% 02 :5% C02. The 37°c sam-
ples were incubated for six minutes, after which they were replaced in an 
ice bath with the o0 c samples. All tubes were centrifuged at 1,000 x g 
for 60 minutes. The supernatant was aspirated and discarded. The pellet 
was vortexed with 1 ml absolute ethanol and immediately rinsed with another 
1 ml of absolute ethanol. These were added to scintillation vials with 
10 ml Econofluor (New England Nuclear Corporation). Protein measurements 
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were carried out using the method of Lowry~~ (1951). Specific synap-
tosomal uptake of (3H)S-HT was calculated by subtracting the mean value 
of the o0 c incubation samples from those obtained from the 37°c incuba-
tions. Radioactivity was measured using a Packard Tri-Carb model 3335 
1 iquid scintillation spectrometer. Uptake was expressed as pM (3H)S-HT/ 
mg protein/six minutes. 
Binding Assays 
The tissue preparation and assay procedure was a modification of 
the method of Peroutka and Snyder (1979). The frozen tissue was weighed 
and placed in 10 volumes of ice-cold 0.32 M sucrose. This was homogen-
ized using a motor-driven teflon-glass pestle. The speed was 1,000 rpm 
and 10 up-and-down strokes were used. The resulting homogenate was cen-
trifuged at 700 x g for 10 minutes. The pellet was discarded. The 
supernatant was removed and centrifuged at 50,000 x g for 10 minutes. 
The resulting pellet was separated from the supernatant and incubated in 
10 volumes of SO mM Tris buffer (pH 7.4 at 25°c) after resuspension. 
After this incubation, the preparation was recentrifuged at 50,000 x g 
for 10 minutes. The supernatant was again discarded and the pellet was 
resuspended in 10 volumes of Tris buffer (pH 7.4 at 25°c) with 1 mg/ml 
abscorbate and 10- 5 M pargyline. This preparation was incubated at 37°c 
for 10 minutes and then frozen at -70°c until use (not more than four 
weeks). 
For assay, the tissue preparation was diluted to 80 volumes. Incu-
bation tubes received 0.8 ml of tissue, 0. 1 ml of (3H)-ligand solution, 
and 0. 1 ml of displacer or buffer. Final tissue concentration was 10 
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mg/ml. The final concentrations of the (3H)-1 igands were 0.2 nM for 
spiroperidol and 2.0 nM for 5-HT. The tubes were incubated at 37°c for 
10 minutes for 5-HT and 15 minute~ for spiroperidol. The samples were 
cooled in an ice bath for 15 minutes after incubation. They were then 
rapidly filtered through Whatman GF/B filters with three 5 ml rinses of 
ice-cold 50 mM Tris buffer (pH 7.4 at 25°c). The filters were heated 
until dried and added to scintillation vials with 10 ml Econofluor. The 
samples were allowed to equilibrate overnight and counted the following 
day in a Packard Tri-Carb model 3335 liquid scintillation spectrometer. 
Specific binding of (3H)5-HT was defined to be the excess over blank in 
the presence of 10- 5 M unlabeled 5-HT and that of (3H)-spiroperidol in 
the presence of 10-6 M unlabeled spiroperidol. (3H)5-HT (26.3 Ci/mM) 
and (3H)-spiroperidol (23.8 Ci/mM) were obtained from New England Nuclear 
Corporation, Boston, Massachusetts . Other reagents were obtained from 
Sigma Chemical Company (St. Louis, Missouri). 
Statistics 
For turnover studies, differences in results were considered insig-
nificant if the standard errors of the means overlapped. In uptake 
studies, the students' t-test was used to determine if differences 
between the drug-treated and control conditions existed. In binding 
studies, I inear regression analysis was utilized to determine the best 
fit on a straight line for the six points of the Scatchard plot. The 
students' t-test was used to determine whether or not the mean kd (dis-
sociation constant, measured as the - inverse of the slope of the line) 
or mean Bmax (maximum number of binding sites, measured as the 11x11 inter-
cept of the line) were different in treated and control groups. 
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RESULTS 
Effect of LSD on 5-HT Turnover 
The effect of an acute dose of 100 ug/kg LSD is shown in figure 1. 
The level of 5-HT at the time of sacrifice was increased from 0.7 ug/g 
to 0.9 ug/g. Also, turnover was inhibited at all time points. Figure 2 
shows the turnover curve for treatment with 1 mg/kg/day LSD for seven 
consecutive days followed by a 14-day period without treatment. Figure 
3 denotes the effect of 0.5 mg/kg/day LSD administered daily for 14 
consecutive days followed by 14 drug-free days. The two-hour point of 
figure 3 was found to show a difference between treated and control. 
Figure 4 shows the effect of 1 mg/kg/day LSD for 14 consecutive days 
followed by one day without treatment prior to sacrifice. Figure 5 
shows the effect of 1 mg/kg/day LSD for 14 consecutive days followed by 
14 days without treatment prior to sacrifice. 
Effect of 5,6-Dihydroxytryptamine .£.!:_LSD on (3H)5-HT Uptake 
lntracerebral injection of 75 ug of 5,6-DHT dissolved in physiolog-
ical saline was shown to reduce (3H)5-HT uptake in rat cerebral cortex 
14 days after administration. Uptake was diminished by 29% from sham-
treated controls. The control value was 2.18 + 0.14, while the 5,6-DHT 
treated value was 1.55::_0.19 (Table 1). Administration of 1 mg/kg/day 
LSD for 14 consecutive days followed by 1 or 14 days without treatment 
prior to sacrifice caused no significant change between drug-treated or 
control (3H)5-HT uptake in the rat cerebral cortex (Table 1). Data is 
expressed as picomoles (3H)5-HT/mg protein/six minutes. 
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Effect of LSD on Affinity Constant and Maximum Number of Binding Sites 
for (3H)5-HT Receptors~ Rat Cerebral Cortex 
Table 2 shows the effects on rats of 1 mg/kg/day LSD for 14 consec-
utive days followed by one drug-free day prior to sacrifice (experiment 
1). The Kd value for control rats was 6.76 + 0.36 mM, while for LSD-
treated rats it was 6.92 + 0.60 nM. The Bmax for the controls was 7.93 
+ 0.42, while for the LSD-treated group it was 8.58 ~ 0.47 pM/g. Exper-
iment 2 shows the effect of 1 mg/kg/day LSD for 14 consecutive days fol-
lowed by 14 days of no treatment prior to sacrifice. The Kd value for 
control was 6.81 ~ 0.66 nM, while for the LSD-treated group it was 6.32 
+ 0.45 nM. The Bmax for the control group was 7.90 + 0.39 pM/g, while 
for the LSD-treated group it was 7.37 + 0.49 pM/g. 
Effect of LSD ~Affinity Constant and Maximum Number of Binding Sites 
for (3H)-Spiroperidol Receptors~ Rat Cerebral Cortex 
Table 3 shows the effects of 1 mg/kg/day LSD for 14 consecutive 
days with one day without treatment prior to sacrifice (experiment 1). 
The Kd value for control rats was 1.09 + 0.046, while for the LSD-treated 
group it was 1. 12+0.150. The Bmax for the control group was 4.15 + 
0.26, while for the LSD-treated group it was 3.79 + 0.48. Experiment 2 
shows the effect of 1 mg/kg/day LSD for 14 consecutive days followed by 
14 days of no treatment prior to sacrifice. The Kd value for the con-
trol group was 1. 16 + 0.09, while for the LSD-treated group it was 1.10 
+ 0.02. The Bmax for the control group was 4.54 .:!:_ 0.54, while for the 
LSD-treated group it was 4.34 + 0.43. Affinity constant data was 
expressed in nanomoles (3H)-l igand and binding site data was expressed 
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in picomoles (3H)-ligand/gram tissue wet weight. Figure 6 shows a typi-
cal Scatchard plot based on the data of Table 2, experiment 2. 
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Table 1. A Comparison of the Effect of 5,6-Dihydroxytryptamine or LSD 
on Synaptosomal Uptake of (3H)5-HT in Rat Cerebral Cortex 
pM (3H)5-HT/mg 
Protein/6 Min ±.. SEM n 
--
Experiment 1 : 
Control 2. 18 + o. 14 3 
5,6-DHT, 75 ug 1. 55 + 0. 19 J:'• 
Experiment 2: 
Control 2.49 + o. 19 3 
LSD, 1 mg/kg/day, 2.26 + 0.25 3 
14 drug-free days 
Experiment 3: 
Control 2.25 + 0.34 3 
LSD, 1 mg/kg/day, 1.92 + 0.40 3 
14 drug-free days 
* Represents statistical significance 
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Table 2. A Comparison of the Effect of LSD on the Affinity Constant and 
Maximum Number of Binding Sites for (3H)5-HT in Rat Cerebral 
Cortex 
Kd (nM) ± SEM Bmax (pM/g) ± SEM n 
Experiment 1 : 
Control 6.76 + 0.36 7.93 + 0.42 3 
LSD, 1 mg/kg/day, 6.92 + 0.60 8.58 + 0.47 3 
drug-free day 
Experiment 2: 
Control 6.81 + 0.66 7.90 + 0.39 5 
LSD, 1 mg/kg/day, 6.32 + 0.45 7.37 + 0.49 5 
14 drug-free days 
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Table 3. A comparison of the Effectof LSD on the Affinity Constant and 
Maximum Number of Binding Sites for (3H)-Spiroperidol in Rat 
Cerebral Cortex 
Kd (nM) ± SEM Bmax · (pM/g) ± SEM n 
-
Experiment l : 
Control l.09 + .046 4.15 + 0.26 3 
LSD, l mg/kg/day, 1. 12 + . 150 3.79 + 0.48 3 
1 drug-free day 
Experiment 2: 
Control 1.16 + .085 4.52 + 0.54 3 
LSD, 1 mg/kg/day, 1.10 + .020 4.34 + 0.43 3 
14· drug-free days 
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LEGENDS TO FIGURES 
Figure _l: Rats were administered 100 ug/kg LSD i.p. six hours prior to 
sacrifice. Rats were sacrificed at 0, 2, and 4 hours after 
treatment with 75 mg/kg pargyline. All data points represent 
the mean of a minimum of four determinations. 
Figure 2: Rats were administered LSD (1 mg/kg/day for seven days), fol-
lowed by 14 days without treatment prior to sacrifice. Rats 
were administered 75 mg/kg pargyline at 0, 2, and 4 hours 
prior to sacrifice. All data points represent the mean of a 
minimum of four determinations. 
Figure 3: Rats were administered .LSD (0.5 mg/kg/day for 14 days), fol-
lowed by 14 days without treatment prior to sacrifice. Rats 
w~re administered pargyl ine,. 75 _mg/.kg i .p., at 0, 2, and 4 
hours prior to sacrifice. All data points represent the mean 
of a minimum of four determinations. 
Figure 4: Rats were administered LSD (1 mg/kg/day for 14 days), fol lowed 
by one day without treatment prtor to sacrifice. Rats were 
administered pargyline, 75 mg/kg i.p., at 0, 2, and 4 hours 
prior to sacrifice. All data points represent the mean of a 
minimum of four determina~lons. 
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Figure 5: Rats were administered LSD (1 mg/kg/day for 14 days), followed 
· by 14 days without treatment prior to sacrifice. Rats were 
administered 75 mg/kg pargyline i.p. at 0, 2, and 4 hours 
p~ior to sacrifice. All data points represent the mean of a 
minimum of six determinattons. 
Figure 6: Data is based on the- results of th~ee experiments. 
X-axis - Picomoles (3H)-spiroperidol/g tissue wet weight. 
Y-axis - Picomoles (3H)-spiroperidol/g tissue/nM (3H)-spiro-
per i do 1 • . 
Correla~ion coefficient - 0.97. 
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Figure.!_. A COMPARISON OF SEROTONIN TURNOVER IN THE CEREBRAL CORTEX OF 
RATS AFTER ACUTE LSD OR SALINE 
1.0 
)Jg SHT lg tissue 
0 
•LSD 
0 Saline 
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Figure~- A COMPARISON OF SEROTONIN TURN.OVER IN THE CEREBRAL CORTEX OF 
RATS AFTER SEVEN CONSECUTIVE DAYS OF TREATMENT WITH LSD OR 
SALINE. FOLLOWED BY FOURTEEN DAYS WITHOUT TREATMENT PRIOR TO 
SACRIFICE 
1. a 
.9 
.8 
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Figure 1·- A COMPARISON OF SEROTONIN TURNOVER IN THE CEREBRAL CORTEX OF 
RATS AFTER- FOURTEEN CONSECUTIVE DAYS OF TREATMENT WITH LSD OR 
SALIN~ FOLLOWED BY FOURTEEN DAYS. WITHOUT TREATMENT PRIOR TO 
SACRI Fl CE. 
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Figure!±.: A COMPARISON OF SEROTONIN TURNOVER lN THE CEREBRAL CORTEX OF 
RATS AFTER FOURTEEN CONSECUTIVE DAYS OF TREATMENT WITH LSD OR 
SALINE FOLLOWED BY ONE DAY WITHOUT TREATMENT PRIOR TO SACRI-
FICE 
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Figure .2: A COMPARISON OF SEROTONrn TURNOVER IN THE CEREBRAL CORTEX OF 
RATS AFTER FOURTEEN CONSECUTIVE OAYS OF TREATMENT WITH LSD OR 
SALINE FOLLOWED BY FOURTEEN DAYS WITHOUT TREATMENT PRIOR TO 
SACRIFICE 
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Figure~· REPRESENTATIVE. SCATCHARD PLOT ANALYSIS OF THE DATA IN TABLE 3, 
EXPERIMENT 2 
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DI SC USS I ON. 
This study has addressed the hypothesis that psychotic effects diag-
nosed as LSD-induced are due to adaptations or alterations of the func-
tioning of 5-HT neurons in the CNS. Acute administration of LSD produces 
a significant elevation in5-HT levels accompanied by a complete cessa-
tion of turnover (Rosecrans~~' 1967). This pharmacologic effect is 
assumed to be related to the human LSD experience due, in part, to the 
information available on the patterns of innervation of 5-HT neurons. 
Raphe nuclei B7 , B8 , and B9 send efferent fibers via the median forebrain 
bundle to the amygdala, thalamus, hippocampus, and cortex (Dahlstrom et 
~' 1964). The fibers of these nuclei are present in the cortex samples 
utilized for this study. 
The results of acute and chronic LSD administration on 5-HT turnover 
suggest that the drug exerts little persistent effect on biochemical par-
ameters which assess function of 5-HT neurons. Chronic administration of 
even 10 times the acute LSD dose for 14 consecutive days resulted in no 
significant alteration in levels or turnover of 5-HT after 1 or 14 days 
without treatment. Acute LSD at 100 ug/_kg (f_igure 1) caused a cessation 
of 5-HT turnover. When levels of 5-HT in cerebral cortex were measured 
six hours after LSD, the treated rats showed no change in 5-HT levels 
over the four hours after pargyline administration, while the control 
rats showed the increase in 5-HT characteristic of all the stuqies. This 
suggests that the levels of 5-HT had risen to a ceiHng value and leveled 
off due to end-product inhibition (inhibition of tryptophan-5-hydroxylase 
by 5-HT). 
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Although the 5-HT level at the two-hour time point of figure 3 is 
significantly different from control, this result can be attributed to 
experimental error. This study was repeated identically with two times 
the dose as shown in figure 5, and the results in this case showed no 
difference from control. Overall, the turnover data suggest that the 
LSD exerts its effects on 5-HT neurons only when it is present in suffi-
cient quantities in the CNS. The possibility of a _residual effect on 
turnover after LSD is eliminated seems, from this data, to be unlikely. 
The synaptosomal uptake of (3H)5-HT was measured after administra-
tion of 5,6-dihydroxytryptamine, a specific 5-HT neurotoxin (Baldessarini 
et~. 1973; Daily et 2..!,. 1973; and Baumgarten et.!!_, 1972). The tri-
cyclic antidepressant, desipramine, was administered one hour prior to 
the 5,6-0HT. Since desipramine is a specific norepinephrine uptake 
blocker, it has been used to improve the specificity of 5,6-DHT for 5-HT 
neurons. The 5,6-DHT was injected intracerebrally into the lateral ven-
tricle since it would have been rapidly metabolized and excluded from 
the CNS if administered parenterally. The 5,6-DHT diminished the uptake 
of (3H)5-HT by 29% (Tablet). Chronic treatment with LSD followed by 1 
or 14 days without treatment produced no alteration in uptake of (3H)5-HT 
in rat cortex (Table 1). Rats given other drugs; for example, metamphet-
amine at 25 mg/kg/day for four days, exhibit impaired uptake of (3H)5-HT 
even after 21 drug-free days (Ricaurte et.!!_, 1981). 
Receptor binding experiments for both (3H)5-HT and (JH)-spiroperidol 
were carried out in order to examine 5-HT receptors according to their 
currently accepted order. That is that the 5-HT receptor in the rat 
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cerebral cortex is made up of two subgroups~ One subgroup binds (3H)5-HT 
and this is displaceable by unlabeled 5-HT with an ICso of approximately 
10-7 M- (Creese and Snyder, 1978; Peroutka and Snyder, 1979). This sug-
gests a . high affini.ty of: this receptor for 5-HT. The other currently 
accepted 5-HT receptor binds (3H)-spiroperidol and this is not easily 
displaced by 5-HT, but is dJsplaceable by 5-HT antagonists such as 
unlabeled spiroperidol, mianserin, or cinanserin (Seeman~~' 1980; 
Qui k et ~' 1978). 
Receptor binding experiments for both (3H)5-HT and (3H)-spiroperidol 
showed no significant changes in Kd or Bmax (Tables 2 and 3). These two 
parameters of receptor populations are frequently used to measure and 
characterize specific neurotransmitter receptors. Other researchers have 
shown the Kd and Bmax of brain _receptor populations. to be adaptable to 
prolonged exposure to certain dr_ugs. Specifically for the 5-HT receptor, 
Akiyama et!.!.. (1982) showed changes in Bmax of (3H)-spiroperidol binding 
after 14 days of 4 mg/.kg/day treatment with methamphetamine fol lowed by 
seven drug-free days. Segawa and Urehara (1981) showed a decrease in 
(3H)5-HT specific binding in rat whole brain preparations after four con-
secutive days of treatment with methiothepin and mianserin, two anti-
depressant drugs. Leysen et~ (1982) showed that mechanically-produced 
cerebral lesions caused a significant decrease in binding sites for the 
spiroperidol-sensitive receptor. Research using the discussed methods 
has yielded knowledge about the dysfunction of the 5·HT system induced 
by toxic agents. The data generated by Diaz and Huttenan (1972) and 
Peters (1973, 1976) suggest that our experiments with LSD, utilizing the 
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described doses (at least 10 times the LSD EDso) and the time periods of 
treatment employed, would have been suitable for uncovering impairments 
in the 5-HT system had they occurred. 
Assuming a psychosis due to exposure to LSD does exist in humans, 
the biochemical alterations accompanying it are not measurable given the 
rat model which we utilized, the treatment conditions employed, and the 
avail~ble methodology. It is the conclusion of this study that no evi-
dence was found to support the hypothesis that LSD produces long-lasting 
alterations in the functioning of 5-HT neurons and that this is the 
basis for LSD-induced psychosis. 
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